Arthrogryposis Multiplex Congenita Neurogenic Type
Symptoms, Doctors, Treatments, Advances & More

Arthrogryposis Multiplex Congenita Neurogenic Type Overview

Save information for later
Sign Up

Learn About Arthrogryposis Multiplex Congenita Neurogenic Type

What is the definition of Arthrogryposis Multiplex Congenita Neurogenic Type?
Arthrogryposis multiplex congenita neurogenic type (AMCN) refers to the development of multiple joint contractures affecting two or more areas of the body prior to birth. A contracture occurs when a joint becomes permanently fixed in a bent or straightened position, which can impact the function and range of motion of the joint and lead to muscle atrophy. Signs and symptoms of AMCN vary. AMCN can affect upper and lower joints, including the wrists, elbows, fingers, knees, ankles, and hip. In AMCN, arthrogryposis occurs as a result of the abnormal development of cells in the spinal cord (anterior horn cells) or brainstem (motor nuclei). AMCN often occurs sporadically (in a person with no family history of the condition), however families with multiple affected members have also been reported. In most cases, the underlying genetic cause remains unknown.
What are the alternative names for Arthrogryposis Multiplex Congenita Neurogenic Type?
  • Arthrogryposis multiplex congenita neurogenic type
  • AMC, neurogenic type
  • AMCN
  • Neurogenic type of AMC
Who are the top Arthrogryposis Multiplex Congenita Neurogenic Type Local Doctors?
Elite in Arthrogryposis Multiplex Congenita Neurogenic Type
Alexander M. Rossor
Elite in Arthrogryposis Multiplex Congenita Neurogenic Type
Alexander M. Rossor
UCL Queen Square Institute Of Neurology, 
London, ENG, GB 

Alexander Rossor practices practicing medicine in London, United Kingdom. Mr. Rossor is rated as an Elite expert by MediFind in the treatment of Arthrogryposis Multiplex Congenita Neurogenic Type. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Charcot-Marie-Tooth Disease, Arthrogryposis Multiplex Congenita Neurogenic Type, Spinal Muscular Atrophy with Arthrogryposis, and Primary Lateral Sclerosis.

Advanced in Arthrogryposis Multiplex Congenita Neurogenic Type
Dr. Mijail D. Serruya
Neurology | Integrative Medicine
Advanced in Arthrogryposis Multiplex Congenita Neurogenic Type
Dr. Mijail D. Serruya
Neurology | Integrative Medicine

Vickie & Jack Farber Institute For Neuroscience - Honickman Center

1101 Chestnut Street, Floor 10, 
Philadelphia, PA 
215-503-1275
Languages Spoken:
English
See accepted insurances

Mijail Serruya is an Integrative Medicine specialist and a Neurologist practicing medicine in Philadelphia, Pennsylvania. Dr. Serruya is rated as an Advanced provider by MediFind in the treatment of Arthrogryposis Multiplex Congenita Neurogenic Type. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Spinal Muscular Atrophy with Arthrogryposis, Arthrogryposis Multiplex Congenita Neurogenic Type, Cerebellar Degeneration, and Normal Pressure Hydrocephalus. Dr. Serruya is board certified in Neurology.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Arthrogryposis Multiplex Congenita Neurogenic Type
Francesco Muntoni
Distinguished in Arthrogryposis Multiplex Congenita Neurogenic Type
Francesco Muntoni
Great Ormond Street Hospital Biomedical Research Centre, 
London, ENG, GB 

Francesco Muntoni practices practicing medicine in London, United Kingdom. Mr. Muntoni is rated as a Distinguished expert by MediFind in the treatment of Arthrogryposis Multiplex Congenita Neurogenic Type. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Becker Muscular Dystrophy, Duchenne Muscular Dystrophy, Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Gastrostomy.

View All Doctors
What are the latest Arthrogryposis Multiplex Congenita Neurogenic Type Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center